Efficacy of the Priority Review Voucher Program.
Duke University, Durham, North Carolina.
David B
DB
Ridley
BIO Ventures for Global Health, Seattle, Washington.
Jennifer
J
Dent
Lion's Head Global Partners, London, United Kingdom.
Christopher
C
Egerton-Warburton
D017277:Drug Approval / Q000191:economics*; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D058069:Neglected Diseases / Q000188:drug therapy*; D016730:Program Development / Q000191:economics*; D035583:Rare Diseases / Q000188:drug therapy*